120 related articles for article (PubMed ID: 31851072)
21. Multiple mechanisms of MYCN dysregulation in Wilms tumour.
Williams RD; Chagtai T; Alcaide-German M; Apps J; Wegert J; Popov S; Vujanic G; van Tinteren H; van den Heuvel-Eibrink MM; Kool M; de Kraker J; Gisselsson D; Graf N; Gessler M; Pritchard-Jones K
Oncotarget; 2015 Mar; 6(9):7232-43. PubMed ID: 25749049
[TBL] [Abstract][Full Text] [Related]
22. Management of bilateral Wilms tumor over three decades: The perspective of a single center.
User IR; Ekinci S; Kale G; Akyüz C; Büyükpamukçu M; Karnak I; Çiftçi AÖ; Tanyel FC; Şenocak ME
J Pediatr Urol; 2015 Jun; 11(3):118.e1-6. PubMed ID: 25842994
[TBL] [Abstract][Full Text] [Related]
23. Retrospective analysis of FFPE based Wilms' Tumor samples through copy number and somatic mutation related Molecular Inversion Probe Based Array.
Singh N; Sahu DK; Goel M; Kant R; Gupta DK
Gene; 2015 Jul; 565(2):295-308. PubMed ID: 25913740
[TBL] [Abstract][Full Text] [Related]
24. Repeat nephron-sparing surgery for children with bilateral Wilms tumor.
Kieran K; Williams MA; McGregor LM; Dome JS; Krasin MJ; Davidoff AM
J Pediatr Surg; 2014 Jan; 49(1):149-53. PubMed ID: 24439600
[TBL] [Abstract][Full Text] [Related]
25. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors.
Hing S; Lu YJ; Summersgill B; King-Underwood L; Nicholson J; Grundy P; Grundy R; Gessler M; Shipley J; Pritchard-Jones K
Am J Pathol; 2001 Feb; 158(2):393-8. PubMed ID: 11159177
[TBL] [Abstract][Full Text] [Related]
26. Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience.
Wilde JC; Aronson DC; Sznajder B; Van Tinteren H; Powis M; Okoye B; Cecchetto G; Audry G; Fuchs J; Schweinitz DV; Heij H; Graf N; Bergeron C; Pritchard-Jones K; Van Den Heuvel-Eibrink M; Carli M; Oldenburger F; Sandstedt B; De Kraker J; Godzinski J
Pediatr Blood Cancer; 2014 Dec; 61(12):2175-9. PubMed ID: 25156758
[TBL] [Abstract][Full Text] [Related]
27. Gain of MYCN region in a Wilms tumor-derived xenotransplanted cell line.
Noguera R; Villamón E; Berbegall A; Machado I; Giner F; Tadeo I; Navarro S; Llombart-Bosch A
Diagn Mol Pathol; 2010 Mar; 19(1):33-9. PubMed ID: 20186010
[TBL] [Abstract][Full Text] [Related]
28. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
[TBL] [Abstract][Full Text] [Related]
29. Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4.
Shamberger RC; Guthrie KA; Ritchey ML; Haase GM; Takashima J; Beckwith JB; D'Angio GJ; Green DM; Breslow NE
Ann Surg; 1999 Feb; 229(2):292-7. PubMed ID: 10024113
[TBL] [Abstract][Full Text] [Related]
30. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
31. New approaches to risk stratification for Wilms tumor.
Nelson MV; van den Heuvel-Eibrink MM; Graf N; Dome JS
Curr Opin Pediatr; 2021 Feb; 33(1):40-48. PubMed ID: 33394739
[TBL] [Abstract][Full Text] [Related]
32. Teratoid Wilms Tumor: Report of Three Cases and Review of the Literature.
Ghamdi DA; Bakshi N; Akhtar M
Turk Patoloji Derg; 2019; 35(1):61-68. PubMed ID: 28272669
[TBL] [Abstract][Full Text] [Related]
33. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
Aronson DC; Hadley GP
Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
[TBL] [Abstract][Full Text] [Related]
34. Pathological review of Wilms tumor nephrectomy specimens and potential implications for nephron sparing surgery in Wilms tumor.
Cost NG; Lubahn JD; Granberg CF; Sagalowsky AI; Wickiser JE; Gargollo PC; Baker LA; Margulis V; Rakheja D
J Urol; 2012 Oct; 188(4 Suppl):1506-10. PubMed ID: 22910241
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of Wilms tumor after apparent cure.
Kim TH; Zaatari GS; Baum ES; Jaffe N; Cushing B; Chard RL; Zwiren GT; Beckwith JB
J Pediatr; 1985 Jul; 107(1):44-9. PubMed ID: 2989472
[TBL] [Abstract][Full Text] [Related]
36. Can we spare removing the adrenal gland at radical nephrectomy in children with wilms tumor?
Moore K; Leslie B; Salle JL; Braga LH; Bägli DJ; Bolduc S; Lorenzo AJ
J Urol; 2010 Oct; 184(4 Suppl):1638-43. PubMed ID: 20728101
[TBL] [Abstract][Full Text] [Related]
37. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines.
Williams RD; Hing SN; Greer BT; Whiteford CC; Wei JS; Natrajan R; Kelsey A; Rogers S; Campbell C; Pritchard-Jones K; Khan J
Genes Chromosomes Cancer; 2004 Sep; 41(1):65-79. PubMed ID: 15236318
[TBL] [Abstract][Full Text] [Related]
38. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
39. Glypican-3 mRNA expression level in Wilms tumor: correlation with histological type, stage, and outcome.
Wari MN; Vallonthaiel AG; Ahmed A; Saxena D; Iyer VK; Mathur SR; Agarwala S; Bakhshi S; Srinivas V; Chattopadhyaya P; Sharma A; Gupta SD; Dinda A
Pediatr Surg Int; 2017 Jun; 33(6):695-703. PubMed ID: 28432433
[TBL] [Abstract][Full Text] [Related]
40. The evolution of treatment for Wilms tumor.
Green DM
J Pediatr Surg; 2013 Jan; 48(1):14-9. PubMed ID: 23331787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
